Quinolone resistance from a transferable plasmid

Lancet

Volumn 351, Issue 9105, 1998, Pages 797-799

  Martínez Martínez, Luis ^c   Pascual, Alvaro ^c   Jacoby, George A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; PEFLOXACIN MESILATE; PORIN; QUINOLONE; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE; TROVAFLOXACIN; VALINE;

AGAR GEL ELECTROPHORESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM CONJUGATION; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPONTANEOUS MUTATION;

EID: 0032515790     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07322-4     Document Type: Article

References (18)

1. 1 Goldstein FW, Acar JF. Epidemiology of quinolone resistance: Europe and North and South America. Drugs 1995; 49 (suppl 2): 36-42.
2. 2 Threlfall EJ, Cheasty T, Graham A, Rowe B. High-level resistance to ciprofloxacin in Escherichia coli. Lancet 1997; 349: 403.
3. 3 Murphy OM, Marshall C, Stewart D, Freeman R. Ciprofloxacin-resistant Enterobacteriaceae. Lancet 1997; 349: 1028-29.
4. 4 Hooper DC, Wolfson JS. Mechanisms of bacterial resistance to quinolones. In: Hooper DC, Wolfson JS, eds. Quinolone antimicrobial agents, 2nd edn. Washington, DC: American Society for Microbiology, 1993: 97-118.
5. 5 Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Molec Biol Rev 1997; 61: 377-92.
6. 6 Munshi MH, Sack DA, Haider K, Ahmed ZU, Rahaman MM, Morshed MG. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 1987; ii: 4419-21.
7. 7 Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob Agents Chemother 1990; 34: 681-84.
8. 8 Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996; 34: 908-11.
9. 9 NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-fourth edition: approved standard M7-A4. Wayne, PA, USA: National Committee for Clinical Laboratory Standards, 1997: 1-29.
10. 10 Medeiros AA, Cohenford M, Jacoby GA. Five novel plasmid-determined β-lactamases. Antimicrob Agents Chemother 1985; 27: 715-19.
11. 11 Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975; 88: 169-78.
12. 12 Macrina FL, Kopecko DJ, Jones KR, Ayers DJ, McCowan SM. A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid 1978; 1: 417-20.
13. 13 Martínez-Martínez L, Hernández-Allés S, Albertí S, Tomás JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 342-48.
14. 14 Tomás JM, Benedí VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54: 85-89.
15. 15 Jacoby GA. Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1974; 6: 239-52.
16. 16 Burman LG. Apparent absence of transferable resistance to nalidixic acid in pathogenic gram-negative bacteria. J Antimicrob Chemother 1977; 3: 509-16.
17. + bacteria. J Gen Microbiol 1968; 50: 173-76.
18. 18 Goldman JD, White DG, Levy SB. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother 1996; 40: 1266-69.